Discover

INTS
Intensity Therapeutics, Inc.
4.28
2 x 3.17
2 x 5.50
bid
ask
+
0.03
0.71%
09:49 AM
timesize
Ytd-58.24%
1y-39.29%
4.23
day range
4.28
3.51
52 week range
43.50
Open4.27Prev Close4.25Low4.23High4.28Mkt Cap13.97M
Vol2.00KAvg Vol44.81KEPS-2.00P/EN/AForward P/E-1.66
Beta2.76Short Ratio3.05Inst. Own12.49%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0750-d Avg4.39200-d Avg6.781yr Est10.00
Income Statement
Operating Expenses3.08M
Research and Development Expense1.83M
Selling, General and Administrative Expense1.25M
Operating Income-3.08M
Net Income-3.01M
Net Income Common Stock-3.01M
Net Income Common Stock (USD)-3.01M
Consolidated Income-3.01M
Earnings per Basic Share-1.11
Earnings per Basic Share (USD)-1.11
Earnings per Diluted Share-1.11
Earning Before Interest & Taxes (EBIT)-3.01M
Earning Before Interest & Taxes (USD)-3.01M
Weighted Average Shares2.71M
Weighted Average Shares Diluted2.71M
Balance Sheet
Cash and Equivalents9.53M
Cash and Equivalents (USD)9.53M
Current Assets11.23M
Property, Plant & Equipment Net82.00K
Total Assets11.52M
Total Debt62.00K
Current Liabilities2.25M
Debt Non-Current62.00K
Total Liabilities2.31M
Accumulated Retained Earnings (Deficit)-83.83M
Shareholders Equity9.21M
Shareholders Equity (USD)9.21M
Assets Non-Current292.00K
Total Debt (USD)62.00K
Liabilities Non-Current62.00K
Trade and Non-Trade Payables1.01M
Cash Flow
Depreciation, Amortization & Accretion7.00K
Net Cash Flow from Financing1.62M
Net Cash Flow / Change in Cash & Cash Equivalents-716.00K
Issuance (Purchase) of Equity Shares1.62M
Net Cash Flow from Operations-2.34M
Share Based Compensation387.00K